Merck (MRK) Long-Term Deferred Tax (2016 - 2023)
Historic Long-Term Deferred Tax for Merck (MRK) over the last 14 years, with Q2 2023 value amounting to $10.2 billion.
- Merck's Long-Term Deferred Tax fell 715.46% to $10.2 billion in Q2 2023 from the same period last year, while for Jun 2023 it was $10.2 billion, marking a year-over-year decrease of 715.46%. This contributed to the annual value of $9.5 billion for FY2022, which is 1773.44% down from last year.
- Merck's Long-Term Deferred Tax amounted to $10.2 billion in Q2 2023, which was down 715.46% from $10.3 billion recorded in Q1 2023.
- In the past 5 years, Merck's Long-Term Deferred Tax registered a high of $11.6 billion during Q4 2021, and its lowest value of $6.8 billion during Q4 2019.
- Moreover, its 5-year median value for Long-Term Deferred Tax was $9.7 billion (2020), whereas its average is $9.6 billion.
- As far as peak fluctuations go, Merck's Long-Term Deferred Tax plummeted by 1900.77% in 2020, and later skyrocketed by 4869.54% in 2021.
- Quarter analysis of 5 years shows Merck's Long-Term Deferred Tax stood at $6.8 billion in 2019, then surged by 45.93% to $9.9 billion in 2020, then rose by 17.21% to $11.6 billion in 2021, then fell by 17.73% to $9.5 billion in 2022, then grew by 6.92% to $10.2 billion in 2023.
- Its Long-Term Deferred Tax was $10.2 billion in Q2 2023, compared to $10.3 billion in Q1 2023 and $9.5 billion in Q4 2022.